Motor symptoms may fluctuate through the entire full time in response to treatment. Therefore, capturing symptoms of them costing only a single time might not be representative of the individual response to treatment and in addition might not capture wearing on / off effects of the procedure. Our Kinesia HomeView technology offers a quantitative platform that may record motor symptoms often per day in addition to diary information that may link dose occasions to responses to supply a far more accurate picture of therapeutic benefits. Great Lakes NeuroTechnologies possess lately received $1.5 million to commercialize an improved technology for assessing Bradykinesia.Look for blue flashes of light. &duplicate; Loralee Leavitt. Used with permission. [Please note: By clicking on this link, you will be leaving this site.].
Arrayit Diagnostics signs special License Agreement with Wayne State University Arrayit Diagnostics, Inc., a majority-possessed subsidiary of Arrayit Company , today announced that it has signed an exclusive License Contract with Wayne Condition University to essential intellectual home covering discoveries of biomarkers of ovarian malignancy. The contract with Wayne Condition University grants Arrayit exclusive worldwide rights to build up and commercialize a novel microarray-based diagnostic check using biomarkers produced by Professors Michael Tainsky of the School of Medication and Sorin Draghici of the faculty of Liberal Arts and Sciences, and Madhumita Chatterjee, research associate in the educational school of Medicine.